Name | Number of supported studies | Average coverage | |
---|---|---|---|
retinal ganglion cell | 3 studies | 20% ± 5% |
Insufficient scRNA-seq data for expression of CHRNB3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 95% | 55.41 | 313 / 328 | 2% | 0.03 | 3 / 178 |
brain | 49% | 43.58 | 1284 / 2642 | 3% | 0.04 | 21 / 705 |
uterus | 5% | 0.96 | 8 / 170 | 0% | 0.01 | 2 / 459 |
ovary | 2% | 0.21 | 4 / 180 | 1% | 0.02 | 5 / 430 |
lung | 2% | 0.30 | 14 / 578 | 1% | 0.01 | 7 / 1155 |
adrenal gland | 1% | 3.09 | 2 / 258 | 1% | 0.05 | 2 / 230 |
eye | 0% | 0 | 0 / 0 | 1% | 0.10 | 1 / 80 |
stomach | 0% | 0 | 0 / 359 | 1% | 0.02 | 3 / 286 |
liver | 0% | 0 | 0 / 226 | 1% | 0.06 | 4 / 406 |
blood vessel | 1% | 0.14 | 11 / 1335 | 0% | 0 | 0 / 0 |
breast | 0% | 0 | 0 / 459 | 1% | 0.02 | 8 / 1118 |
esophagus | 0% | 0.01 | 2 / 1445 | 1% | 0.02 | 1 / 183 |
skin | 0% | 0.03 | 5 / 1809 | 0% | 0.00 | 1 / 472 |
heart | 0% | 0.07 | 4 / 861 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 0% | 0.01 | 2 / 504 |
peripheral blood | 0% | 0.04 | 3 / 929 | 0% | 0 | 0 / 0 |
intestine | 0% | 0 | 0 / 966 | 0% | 0.00 | 1 / 527 |
thymus | 0% | 0 | 0 / 653 | 0% | 0.01 | 1 / 605 |
muscle | 0% | 0.01 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 0% | 0 | 0 / 901 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
prostate | 0% | 0 | 0 / 245 | 0% | 0 | 0 / 502 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051899 | Biological process | membrane depolarization |
GO_0060079 | Biological process | excitatory postsynaptic potential |
GO_0007165 | Biological process | signal transduction |
GO_0034220 | Biological process | monoatomic ion transmembrane transport |
GO_0095500 | Biological process | acetylcholine receptor signaling pathway |
GO_0099171 | Biological process | presynaptic modulation of chemical synaptic transmission |
GO_0035094 | Biological process | response to nicotine |
GO_0007271 | Biological process | synaptic transmission, cholinergic |
GO_0098793 | Cellular component | presynapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0098691 | Cellular component | dopaminergic synapse |
GO_0043005 | Cellular component | neuron projection |
GO_0045202 | Cellular component | synapse |
GO_0045211 | Cellular component | postsynaptic membrane |
GO_0005892 | Cellular component | acetylcholine-gated channel complex |
GO_1901363 | Molecular function | heterocyclic compound binding |
GO_0015267 | Molecular function | channel activity |
GO_0015464 | Molecular function | acetylcholine receptor activity |
GO_0042166 | Molecular function | acetylcholine binding |
GO_0022848 | Molecular function | acetylcholine-gated monoatomic cation-selective channel activity |
Gene name | CHRNB3 |
Protein name | Cholinergic receptor nicotinic beta 3 subunit Neuronal acetylcholine receptor subunit beta-3 |
Synonyms | |
Description | FUNCTION: After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. |
Accessions | Q05901 A0A1D5RMT8 ENST00000289957.3 ENST00000534391.1 |